- About Us
- Climate & Environment
- Diversity, Equity & Inclusion
- Governance
- Stories
Chubb’s culture is defined by who we are, the behaviors we expect of each other, and what we reward and recognize.
Chubb Group Executives
Chubb has operations in 54 countries and territories and can help clients manage their risks anywhere in the world.
The company took its present form in 2016 when ACE Limited acquired the Chubb Corporation, creating a world leader in insurance.
Chubb Climate+ draws on our extensive technical capabilities in underwriting and risk engineering, bringing together Chubb units engaged in Renewables, Alternative Fuels, Climate Tech, and Risk Engineering services.
At Chubb, we recognize our responsibility to provide solutions that help clients manage environmental risks, to reduce our own environmental impact and to make meaningful contributions to environmental causes.
Chubb has developed a series of accelerator programs around the world designed for women at all stages of their career.
The path towards racial justice and equity is both an individual journey and collective duty.
Building and advancing a fair, equitable and inclusive workplace is a journey that requires commitment and action.
Guided by steady leadership and a commitment to the highest levels of personal and professional integrity.
Robert J. Hugin
Robert J. Hugin
Former Chairman and Chief Executive Officer
Celgene Corporation
Robert J. Hugin served as Chief Executive Officer of Celgene Corporation (a biopharmaceutical company) from June 2010 until March 2016, as Chairman of its Board of Directors from June 2011 to March 2016 and as Executive Chairman from March 2016 to January 2018. Prior to June 2016, Mr. Hugin held a number of management roles at Celgene, including President from May 2006 to July 2014, Chief Operating Officer from May 2006 to June 2010 and Senior Vice President and Chief Financial Officer from June 1999 to May 2006. Prior to that, Mr. Hugin was a Managing Director at J.P. Morgan & Co. Inc., which he joined in 1985. Mr. Hugin is currently a director of Biohaven Pharmaceutical Holding Company Ltd. (pharmaceutical company). Mr. Hugin has previously served as a director of Allergan plc (multispecialty health care company), Danaher Corporation (science and technology company) and The Medicines Company (pharmaceutical company).
Mr. Hugin brings significant and extensive executive leadership to our Board. His experience as a chief executive officer and his outside board service enables him to provide valuable insight on complex business and financial matters and guidance to our management on strategy. In addition, his role as chairman and chief executive of a global public company provides a depth of knowledge in handling a broad array of complex operational, regulatory and international issues.
Source: Chubb Limited Proxy Statement filed April 1, 2024